IMVT icon

Immunovant

197 hedge funds and large institutions have $1.97B invested in Immunovant in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 82 increasing their positions, 65 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

6% less funds holding

Funds holding: 209197 (-12)

13% less capital invested

Capital invested by funds: $2.27B → $1.97B (-$300M)

29% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 35

Holders
197
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$24.3M
Puts
$23.6M
Net Calls
Net Calls Change

Top Buyers

1 +$74.7M
2 +$63.1M
3 +$42.9M
4
AC
Armistice Capital
New York
+$32.5M
5
PBA
Paradigm Biocapital Advisors
New York
+$14.9M

Top Sellers

1 -$44.7M
2 -$31.7M
3 -$27.4M
4
State Street
State Street
Massachusetts
-$24.4M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$20.4M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1.33M
102
$1.32M
103
$1.3M
104
$1.26M
105
$1.18M
106
$1.1M
107
$1.06M
108
$993K
109
$991K
110
$975K
111
$972K
112
$964K
113
$887K
114
$868K
115
$834K
116
$824K
117
$815K
118
$811K
119
$797K
120
$724K
121
$690K
122
$685K
123
$665K
124
$630K
125
$587K